Position in FENC
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$67,725
+$35,745 QoQ
Shares Held
6,300
+21.2% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 104 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FENC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STRS OHIO holds $177,004,891 across 155 Biotechnology names. FENC ranks #130 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
66,679 | $33,121,459 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,557 | $17,806,431 | |
| 3 | MRNA |
Moderna, Inc.
|
209,874 | $14,697,476 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
299,838 | $10,611,266 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
54,428 | $10,193,275 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,364 | $10,043,564 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
38,166 | $3,026,182 | |
| 8 | EXEL |
Exelixis, Inc.
|
52,093 | $2,834,380 |
All Filings in FENC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,725 | 6,300 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $31,980 | 5,200 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $40,040 | 5,200 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $48,672 | 5,200 | Shares | Sole | 2025-10-30 | |
| 2021-03-31 | $96,255 | 15,500 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $115,475 | 15,500 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $93,930 | 15,500 | Shares | Sole | 2020-12-14 | |
| 2020-06-30 | $129,425 | 15,500 | Shares | Sole | 2020-07-23 | |
| No filing history on record for this holder in this stock. | ||||||